Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis

Bibliographic Details
Main Author: Manica, Santiago Rodrigues
Publication Date: 2020
Other Authors: Sepriano, Alexandre, M. Pimentel-Santos, F., Gouveia, Nélia, Barcelos, Anabela, Branco, Jaime, Bernardes, Miguel, Ferreira, Raquel Miriam, Vieira-Sousa, Elsa, Barreira, Sofia, Vinagre, Filipe, Roque, Raquel, Santos, Helena, Madeira, Nathalie, Rovisco, João, Daniel, Alexandra, Ramiro, Sofia
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/103791
Summary: 57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015).
id RCAP_a63da268e4438fe28dcee13589ac9162
oai_identifier_str oai:run.unl.pt:10362/103791
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritisIs the reason to switch relevant?Ankylosing spondylitisASaxSpAbDMARDnr-axSpAr-axSpASpondyloarthritisSwitchTNFiTreatmentRheumatologyImmunology and AllergyImmunology57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015).Background: To investigate whether the reason to discontinue the first TNF inhibitor (TNFi) affects the response to the second TNFi in axial spondyloarthritis (axSpA). Methods: Patients with axSpA from the Rheumatic Diseases Portuguese Register (ReumaPt), who discontinued their first TNFi and started the second TNFi between June 2008 and May 2018, were included. Response was assessed by the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinically important improvement (ASDAS-CII), major important improvement (ASDAS-MI), low disease activity (ASDAS-LDA), and inactive disease (ASDAS-ID). The reason for discontinuation of the first TNFi was defined, according to ASDAS-CII as primary failure (no response ≤ 6 months), secondary failure (response ≤ 6 months but lost thereafter), adverse events, and others. The association between the reason for discontinuation of the first TNFi and response to the second TNFi over time was assessed in multivariable generalized equation (GEE) models. Results: In total, 193 patients were included. The reason for discontinuation of the first TNFi did not influence the response to the second TNFi, according to the ASDAS-CII. However, a difference was found with more stringent outcomes, e.g., there was a higher likelihood to achieve ASDAS-ID with the second TNFi for patients discontinuing the first TNFi due to secondary failure (OR 7.3 [95%CI 1.9; 27.7]), adverse events (OR 9.1 [2.5; 33.3]), or other reasons (OR 7.7 [1.6; 37.9]) compared to primary failure. Conclusion: Patients with axSpA with secondary failure to their first TNFi, compared to those with primary failure, have a better response to the second TNFi according to stringent outcomes.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNManica, Santiago RodriguesSepriano, AlexandreM. Pimentel-Santos, F.Gouveia, NéliaBarcelos, AnabelaBranco, JaimeBernardes, MiguelFerreira, Raquel MiriamVieira-Sousa, ElsaBarreira, SofiaVinagre, FilipeRoque, RaquelSantos, HelenaMadeira, NathalieRovisco, JoãoDaniel, AlexandraRamiro, Sofia2020-09-09T02:37:28Z2020-08-212020-08-21T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/103791eng1478-6354PURE: 19742660https://doi.org/10.1186/s13075-020-02288-8info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-09-23T01:38:04Zoai:run.unl.pt:10362/103791Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T17:18:38.931287Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
Is the reason to switch relevant?
title Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
spellingShingle Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
Manica, Santiago Rodrigues
Ankylosing spondylitis
AS
axSpA
bDMARD
nr-axSpA
r-axSpA
Spondyloarthritis
Switch
TNFi
Treatment
Rheumatology
Immunology and Allergy
Immunology
title_short Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
title_full Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
title_fullStr Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
title_full_unstemmed Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
title_sort Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis
author Manica, Santiago Rodrigues
author_facet Manica, Santiago Rodrigues
Sepriano, Alexandre
M. Pimentel-Santos, F.
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira-Sousa, Elsa
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
author_role author
author2 Sepriano, Alexandre
M. Pimentel-Santos, F.
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira-Sousa, Elsa
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
RUN
dc.contributor.author.fl_str_mv Manica, Santiago Rodrigues
Sepriano, Alexandre
M. Pimentel-Santos, F.
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira-Sousa, Elsa
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
dc.subject.por.fl_str_mv Ankylosing spondylitis
AS
axSpA
bDMARD
nr-axSpA
r-axSpA
Spondyloarthritis
Switch
TNFi
Treatment
Rheumatology
Immunology and Allergy
Immunology
topic Ankylosing spondylitis
AS
axSpA
bDMARD
nr-axSpA
r-axSpA
Spondyloarthritis
Switch
TNFi
Treatment
Rheumatology
Immunology and Allergy
Immunology
description 57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015).
publishDate 2020
dc.date.none.fl_str_mv 2020-09-09T02:37:28Z
2020-08-21
2020-08-21T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/103791
url http://hdl.handle.net/10362/103791
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1478-6354
PURE: 19742660
https://doi.org/10.1186/s13075-020-02288-8
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596601236455424